Who owns INDAPTUS THERAPEUTICS INC?
- Ticker: INDP
- CUSIP Number: 45339j105
Tip: Access positions for across all investors
Analyze quarterly positions in Indaptus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Indaptus Therapeutics stock
Who bought or sold INDAPTUS THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 256k | $574k | 0% | Mar 2024 |
|
Investment House | 102k | $230k | 0% | Mar 2024 |
|
Geode Capital Management | 55k | $123k | 0% | Mar 2024 |
|
Strategy Asset Managers | 45k | $102k | 0% | Mar 2024 |
|
Pine Valley Investments Ltd Liability | 44k | $99k | 0% | Mar 2024 |
|
Vivaldi Capital Management | 24k | $52k | 0% | Mar 2024 |
|
Tower Research Capital | 4.1k | $9.1k | 34% | Mar 2024 |
|
UBS Group | 1.9k | $4.3k | -48% | Mar 2024 |
|
Morgan Stanley | 884.00 | $2.0k | -14% | Mar 2024 |
|
Bangor Savings Bank | 400.00 | $896.000000 | 0% | Mar 2024 |
|
Wells Fargo & Company | 105.00 | $235.609500 | 1% | Mar 2024 |
|
Jpmorgan Chase & Co | 14.00 | $31.000200 | 56% | Mar 2024 |
|
Group One Trading | 7.00 | $15.999900 | 0% | Mar 2024 |
|
Qube Research & Technologies | 1.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Indaptus Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citadel Advisors | Dec 2023 | 17k | $29k |
Royal Bank of Canada | Dec 2023 | 38.00 | $0 |
Bank of America Corporation | Dec 2023 | 3.00 | $5.000100 |